Reply to "Contradictory Results with High-Dosage Rifamycin in Mice and Humans"

  • E. L. Nuermberger, I. M. Rosenthal, R. Tasneen, C. A. Peloquin, K. E. Mdluli, P. C. Karakousis, J. H. Grosset
  • Antimicrobial Agents and Chemotherapy, January 2013, ASM Journals
  • DOI: 10.1128/aac.02216-12

The authors haven't yet claimed this publication.

Read Publication

In partnership with: